Transderm scop and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Transderm scop (scopolamine) and Methotrexate (methotrexate sodium). Common drug interactions include back pain among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Transderm scop and Methotrexate. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.



On Jul, 05, 2026

43 people who take Transderm scop and Methotrexate together, and have interactions are studied.

Transderm scop and Methotrexate drug interactions.

What are the common drug interactions of Transderm Scop and Methotrexate, by gender? *:

female:

  1. Back pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cystitis (inflammation of the wall of the bladder)
  4. Depression
  5. Diarrhoea
  6. Drug ineffective
  7. Migraine (headache)
  8. Pain in extremity
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Abdominal discomfort

male:

  1. Abdominal pain
  2. Blood bilirubin increased
  3. Agitation (state of anxiety or nervous excitement)
  4. Ammonia increased
  5. Apnoea (suspension of external breathing)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Chest discomfort
  8. Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
  9. Coagulopathy (blood's ability to clot is impaired)
  10. Confusional state

What are the common drug interactions of Transderm Scop and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Fluid overload (too much fluid in the blood)
  3. Gallbladder enlargement
  4. Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
  5. Hallucination (an experience involving the perception of something not present)
  6. Headache (pain in head)
  7. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  8. Hepatic failure (liver failure)
  9. Hepatomegaly (abnormal enlargement of the liver)
  10. Hyperbilirubinaemia (excess of bilirubin in the blood)

20-29:

  1. Hepatobiliary disease (diseases affect the liver and/or biliary tract)
  2. Joint range of motion decreased (disease of joint movement)
  3. Mobility decreased (ability to move is reduced)

30-39:

n/a

40-49:

  1. Anxiety
  2. Benign neoplasm of adrenal gland (benign (non-cancerous) tumours of the adrenal gland)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cervix carcinoma (cancer of cervix)
  5. Depression
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Immune system disorder
  8. Injection site swelling
  9. Mass
  10. Migraine (headache)

50-59:

  1. Wrist surgery
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Blood cholesterol increased
  5. Depression
  6. Nystagmus (a condition of involuntary eye movement)
  7. Oral torus (a lesion made of compact bone and occurs along the palate or the mandible inside the mouth)
  8. Osteonecrosis (death of bone)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

  1. Back pain
  2. Diarrhoea
  3. Blood potassium increased
  4. Blood pressure decreased
  5. Blood pressure increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Carbon dioxide increased
  8. Cardioversion
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colitis (inflammation of colon)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 25.58%
  2. Pain: 11 people, 25.58%
  3. Nausea (feeling of having an urge to vomit): 10 people, 23.26%
  4. Constipation: 9 people, 20.93%
  5. Indigestion: 7 people, 16.28%
  6. Nausea And Vomiting: 6 people, 13.95%
  7. Depression: 5 people, 11.63%
  8. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 5 people, 11.63%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 11.63%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Transderm scop and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Transderm scop and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Transderm scop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Transderm scop and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on scopolamine and methotrexate sodium (the active ingredients of Transderm scop and Methotrexate, respectively), and Transderm scop and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: